Advisory Services Network, LLC I Mab Transaction History

Advisory Services Network, LLC

  • $4.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$57.18 - $84.43 $14,295 - $21,107
-250 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$47.86 - $83.95 $11,965 - $20,987
250 New
250 $21,000
Q1 2021

May 24, 2021
SELL
$44.38 - $63.97 $11,095 - $15,992
-250 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$27.46 - $47.03 $6,865 - $11,757
250 New
250 $12,000

Others Institutions Holding IMAB

# of Institutions
36
Shares Held
15.5M
Call Options Held
56.4K
Put Options Held
5.8K
View Full List

About I-Mab

IMAB Quotes by TradingView
  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $78.9M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email